CIRM Funded Clinical Trials

Inhibitory Interneuron Cell Therapy (NRTX-1001) for the Treatment of Drug-resistant Bilateral Temporal Lobe Epilepsy

Disease Area:
Epilepsy
Investigator:
Institution:
CIRM Grant:
CLIN2-17135 (Pre-Active)
Award Value:
$13,999,983.00
Trial Sponsor:
Neurona Therapeutics
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A